SGEN Financial Facts

Net income (loss): -16.26M
Research and development: 47.74M
See Full Income Statement

Accumulated other comprehensive loss: 27K
Total current assets: 430.94M
See Full Balance Sheet

Earnings History for Seattle Genetics Inc. (SGEN)

  |   Expand Research on SGEN
Next EPS Date 8/7/13 *Est. EPS Growth Rate -27.3% *Last Qtr.
Average EPS % Beat Rate +17.0% Revenue Growth Rate +18.9% *Last Qtr.
Average % Move 1-Wk after EPS +2.1%    
Date  Qtr EPS Cons. Surprise Revs Cons. Estimize EPS/Revs Gd. % Since Details
8/4/11 Q211 -$0.45-$0.39 -$0.06$13.1M$10.97M N/A / N/A = +155.9% Details
11/3/11 Q311 -$0.35-$0.46 +$0.11$20M$13.57M N/A / N/A = +67.1% Details
2/8/11 Q410 -$0.34-$0.38 +$0.04$8.1M$11.22M N/A / N/A = +130.5% Details
5/5/11 Q111 -$0.30-$0.37 +$0.07$12.2M$9.84M N/A / N/A = +123.4% Details
2/13/12 Q411 -$0.24-$0.31 +$0.07$48.9M$39.12M N/A / N/A N/A +93.2% Details
8/8/12 Q212 -$0.15-$0.15 $0.00$48.8M$50.33M N/A / N/A N/A +53.7% Details
5/7/13 Q113 -$0.14-$0.20 +$0.06$57.3M$53.72M N/A / N/A N/A +3.6% Details
11/7/12 Q312 -$0.12-$0.15 +$0.03$49.8M$52.66M $-0.13 / $52.84M N/A +50% Details
Like SGEN Earnings? Also take a look at ABT, VRTX, BIIB, AMGN

SGEN Earnings News